| Literature DB >> 36233606 |
Alfredo Raglio1, Roberto Maestri2, Elena Robbi3, Antonia Pierobon4, Maria Teresa La Rovere3, Gian Domenico Pinna2.
Abstract
It is proven that music listening can have a therapeutic impact in many clinical fields. However, to assume a curative value, musical stimuli should have a therapeutic logic. This study aimed at assessing short-term effects of algorithmic music on cardiac autonomic nervous system activity. Twenty-two healthy subjects underwent a crossover study including random listening to relaxing and activating algorithmic music. Electrocardiogram (ECG) and non-invasive arterial blood pressure were continuously recorded and were later analyzed to measure Heart Rate (HR) mean, HR variability and baroreflex sensitivity (BRS). Statistical analysis was performed using a general linear model, testing for carryover, period and treatment effects. Relaxing tracks decreased HR and increased root mean square of successive squared differences of normal-to-normal (NN) intervals, proportion of interval differences of successive NN intervals greater than 50 ms, low-frequency (LF) and high-frequency (HF) power and BRS. Activating tracks caused almost no change or an opposite effect in the same variables. The difference between the effects of the two stimuli was statistically significant in all these variables. No difference was found in the standard deviation of normal-to-normal RR intervals, LFpower in normalized units and LFpower/HFpower variables. The study suggests that algorithmic relaxing music increases cardiac vagal modulation and tone. These results open interesting perspectives in various clinical areas.Entities:
Keywords: algorithmic music; cardiac autonomic nervous system; music listening; music therapy; physiological parameters
Year: 2022 PMID: 36233606 PMCID: PMC9571939 DOI: 10.3390/jcm11195738
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Figure 1Algorithmic Music (creation process).
Figure 2Schematic diagram of the experimental design of the study. Each recording subsection (baseline, stimulation, recovery) lasted 5 min. Act = activating; Rel = relaxing.
Summary statistics of heart rate and cardiovascular variability indices in the two baseline conditions and during the subsequent relaxing (Rel) and activating (Act) musical stimulation.
| Variable | Rel | Rel | Act | Act |
|---|---|---|---|---|
| HR, bpm | 73.4 ± 2.2 | 72.2 ± 2.1 | 73.5 ± 2.1 | 73.3 ± 2.1 |
| SDNN, ms | 42.8 ± 2.6 | 40.9 ± 2.5 | 44.7 ± 3.2 | 40.3 ± 2.8 |
| RMSSD, ms | 30.8 ± 2.2 | 33.0 ± 2.3 | 35.0 ± 3.4 | 30.3 ± 2.7 |
| pNN50, % | 11.7 ± 2.6 | 14.1 ± 2.6 | 12.6 ± 2.7 | 11.1 ± 2.5 |
| LFpower, ms2 | 559 ± 87 | 644 ± 108 | 712 ± 144 | 512 ± 105 |
| LFNUr, N.U. | 51.7 ± 4.4 | 50.5 ± 4.2 | 53.9 ± 4.7 | 53.2 ± 4.1 |
| HFpower, ms2 | 443 ± 65 | 519 ± 59 | 479 ± 90 | 408 ± 62 |
| LF/HF, A.U. | 1.51 ± 0.26 | 1.37 ± 0.22 | 1.78 ± 0.34 | 1.51 ± 0.22 |
| BRS, ms/mm Hg | 6.0 ± 0.6 | 7.0 ± 0.7 | 6.3 ± 0.6 | 5.9 ± 0.5 |
Summary statistics are expressed as mean ± SEM. HR = mean heart rate; SDNN = standard deviation of normal-to-normal RR intervals; RMSSD = root mean square of successive squared differences of NN intervals; pNN50 = proportion of interval differences of successive NN intervals greater than 50 ms; LFpower = low frequency power; HFpower = high frequency power; LFNU = low frequency power in normalized units; LF/HF = LFpower/HFpower; A.U. = arbitrary units; BRS: baroreflex sensitivity.
Summary statistics of the difference between the value of heart rate and cardiovascular variability indices during stimulation and that during the preceding baseline condition (stimulation effect), with the significance probability of the tests for the carryover and period effects, and for the difference between the effects of the two treatments.
| Variable | Rel | Act | |||
|---|---|---|---|---|---|
| HR, bpm | −1.2 ± 0.4 †† | −0.2 ± 0.3 | 0.63 | 0.36 | 0.018 |
| SDNN, ms | −1.9 ± 1.4 | −4.4 ± 1.9 † | 1.0 | 0.82 | 0.31 |
| RMSSD, ms | 2.2 ± 1.0 † | −4.7 ± 1.7 †† | 0.87 | 0.53 | 0.0002 |
| pNN50, % | 2.4 ± 1.1 † | −1.5 ± 0.8 | 0.95 | 0.61 | 0.010 |
| LFpower, ms2 | 85 ± 50 * | −201 ± 88 * | 0.72 | 0.47 | 0.015 |
| LFNU, N.U. | −1.2 ± 2.7 | −0.7 ± 2.6 | 0.97 | 0.88 | 0.89 |
| HFpower, ms2 | 76 ± 50 * | −72 ± 54 | 0.69 | 0.78 | 0.05 |
| LF/HF, A.U. | −0.14 ± 0.23 | −0.27 ± 0.21 | 0.40 | 0.85 | 0.72 |
| BRS, ms/mm Hg | 1.0 ± 0.4 † | −0.4 ± 0.4 | 0.73 | 0.48 | 0.018 |
Summary statistics are expressed as mean ± SEM. HR = mean heart rate; SDNN = standard deviation of normal-to-normal RR intervals; RMSSD= root mean square of successive squared differences of NN intervals; pNN50 = proportion of interval differences of successive NN intervals greater than 50 ms; LFpower = low frequency power; HFpower = high frequency power; LFNU = low frequency power in normalized units; LF/HF = LFpower/HFpower; A.U.= arbitrary units; BRS: baroreflex sensitivity. In some variables with non-normal distribution (RMSSD, LFpower, HFpower, LF/HF; see text), treatment effects were estimated using a non-parametric approach. * borderline non-significant (0.05 < p < 0.11); † p < 0.05; †† p < 0.005.